BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » cellular therapies

More than 50% of Mesenchymal Stem Cell (MSC) Publications Pertain to Humans

July 26, 2016 By Cade Hildreth (CEO) Leave a Comment

Breakdown of MSC Scientific Publications by Species

Recently, we released an article highlighting that mesenchymal stem cell (MSC) scientific publications have increased in number for 26 years straight. Wow, that is a shockingly consistent trend.

Fascinatingly, two-thirds of those publications were released in the past 5 years, even though there is now a forty-year history of MSC publications.

What is equally fascinating is that the PubMed “Species” sort function indicates that 15,808 of all MSC scientific publications (28,597 to date) pertain to “Humans” rather than “Other Animals.”

Breakdown of MSC Scientific Publications by Species
More than half of all MSC scientific publications pertain to humans, rather than other species.

Having 55.3% of MSC publications pertain to humans is an extremely promising finding for translating MSC research into therapeutic applications.

Whether you are manufacturing stem cell products, developing 3D printing applications, or offering cord blood and tissue storage services, you need to be aware of trends like this.

Explore our blog for more free content on mesenchymal stem cell (MSC) market trends or check out the global strategic report “Mesenchymal Stem Cells – Advances & Applications.”

*Note: PubMed search of terms “mesenchymal stem cell” and “mesenchymal stem cells” executed July 15, 2016.

About BioInformant

BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, Vogue Magazine, and more. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

Filed Under: MSCs, Stem Cells Tagged With: cellular therapies, MSC, trends

National Marrow Donor Program/Be The Match Announces New Cellular Therapies Subsidiary

January 22, 2016 By Cade Hildreth (CEO) Leave a Comment

National Marrow Donor Program/Be The Match Announces New Cellular Therapies Subsidiary

Founded in 1986 in Minneapolis, MN, the National Marrow Donor Program (NMDP) is a nonprofit organization  that operates the Be The Match Registry of volunteer hematopoietic cell donors and umbilical cord blood units in the United States. In major news released today, it announced that it is forming a new subsidiary called “Be The Match BioTherapies,” a division of the group that will focus on partnering with organizations developing cellular therapies.

To learn more, read the full press release, published below with permission from Jeffrey Chell, M.D., Chief Executive Officer of the NMDP/Be The Match. [Read more…]

Filed Under: HSCs, Stem Cells Tagged With: cellular therapies, market news, NMDP, press release

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.